About Signal Bay, Inc.: Signal Bay, Inc., through its subsidiaries Signal Bay Research, Inc., Signal Bay Services, Inc. and EVIO Labs, Inc., provides licensing and compliance services, advisory services, and analytical testing services to the legal cannabis industry. Learn more at SignalBay.com. Notice Regarding Forward-Looking Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Contact: William Waldrop firstname.lastname@example.org (541) 633-4568
Bend, OR, July 14, 2016 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTC PINK: SGBY) a leading provider of cannabis consulting, operations, and laboratory services achieved another milestone today. The company has exceeded 700 total business accounts and as a result has captured significant market share. CEO William Waldrop stated, "We could not be more pleased with our revenue growth, especially over the past couple of months. We have established a reputation of trust, integrity and efficiency and word is traveling fast. Combine that with our aggressive approach with marketing and sales and it is a given that we will exceed 1,000 accounts in short order. We are happy to report that this near-term growth will be achieved through our existing facilities and only scratches the surface when it comes to our potential." Signal Bay operates state-of-the-art testing facilities and offers reliable testing methodologies that ensure the safety and potency of the nation's cannabis supply. As the legalization of medical and recreation marijuana continues across the country, demand for reliable cannabis testing facilities is increasing exponentially. Mr. Waldrop went on to say, "We continue on a weekly basis to refine our procedures and protocols with any eye toward expansion. The more we streamline our business operations, the closer we get to scalability. Increased demand across the country combined with a scalable business model is a recipe for tremendous success. Our goal is "turn-key" labs that can be up and running quickly in markets that we find attractive." Mr. Waldrop finished up with a message to current and potential investors. "We have a strong and growing revenue base, plans for expansion and a solid, stable share structure. In our opinion, the company is undervalued, so let me put this rumor to rest once and for all . . . we have no plans in the foreseeable future for a reverse split . . . period, and we will only increase the number of common or preferred shares of our company with the interest of the business and shareholders in mind. I want to reassure our shareholders that as we grow, we want your share value to grow right along with us. We want to thank you for your interest in our company and your continued support. We plan to release a series of press releases over the coming weeks and month as an effort to keep our shareholders more up to date on existing operations and plans for the future."